Intensive lipid-lowering therapy, time to think beyond low-density lipoprotein cholesterol

Statins have been shown to be effective in reducing cardiovascular events. Their magnitude of benefits has been proportionate to the reduction in low-density lipoprotein cholesterol (LDL-c). Intensive lipid-lowering therapies using ezetimibe and more recently proprotein convertase subtilisin kexin 9...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdalwahab, Ahmed, Al-atta, Ayman, Zaman, Azfar, Alkhalil, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462038/
https://www.ncbi.nlm.nih.gov/pubmed/34621492
http://dx.doi.org/10.4330/wjc.v13.i9.472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462038/
https://www.ncbi.nlm.nih.gov/pubmed/34621492
http://dx.doi.org/10.4330/wjc.v13.i9.472

Ejemplares similares